← All trials
NCT02077361
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2015
- Primary completion
- Jun 30, 2017
- Completion date
- Dec 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 6
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of AlbertaLead sponsor
- University of AlbertaOverall official - principal investigator
- University of AlbertaSponsor investigator
- University of LondonCollaborator
- Alberta Innovates Health SolutionsCollaborator
- Canada Foundation for InnovationCollaborator
- Canadian Institutes of Health Research (CIHR)Collaborator
- Choroideremia Research Foundation CanadaCollaborator
- Foundation Fighting BlindnessCollaborator
- University of OxfordCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.